A study of MOG-IgG detected by western blot in patients with clinical isolated syndrome found that antibody positivity was a significant predictor of early conversion to clinically definite MS, but this finding was not reproducible in another study using the same western blot protocol (52, 53). The gene discussed is MOG; the disease is myeloid sarcoma.